INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $221,955 | -98.5% | 4,261 | -98.1% | 0.00% | -97.8% |
Q2 2023 | $14,534,220 | +4112.8% | 229,536 | +2155.0% | 0.04% | +2150.0% |
Q1 2021 | $345,000 | -13.8% | 10,179 | -60.8% | 0.00% | -33.3% |
Q1 2020 | $400,000 | -84.3% | 26,000 | -86.8% | 0.00% | -66.7% |
Q2 2019 | $2,555,000 | -13.7% | 196,803 | -19.0% | 0.01% | -18.2% |
Q1 2019 | $2,960,000 | +30.1% | 243,003 | +21.6% | 0.01% | +10.0% |
Q4 2018 | $2,276,000 | -65.3% | 199,803 | -33.9% | 0.01% | -58.3% |
Q3 2018 | $6,561,000 | +12.8% | 302,348 | -8.1% | 0.02% | 0.0% |
Q2 2018 | $5,814,000 | +27.4% | 329,048 | +51.8% | 0.02% | +14.3% |
Q1 2018 | $4,563,000 | – | 216,759 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |